American Regent Inc. Issues Voluntary Nationwide Recall of One Lot of Papaverine Hydrochloride Injection USP 60 Mg/ 2 ML Due to the Presence of Visible Particulate Matter
July 28, 2026
July 28, 2026
WASHINGTON, July 28 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following recall notice:
* * *
American Regent, Inc. Issues Voluntary Nationwide Recall of One Lot of Papaverine Hydrochloride Injection, USP 60 mg/ 2 mL Due to the Presence of Visible Particulate Matter
Summary
Company Announcement Date: July 24, 2026
FDA Publish Date: July 27, 2026
Product Type: Drugs
. . .
* * *
American Regent, Inc. Issues Voluntary Nationwide Recall of One Lot of Papaverine Hydrochloride Injection, USP 60 mg/ 2 mL Due to the Presence of Visible Particulate Matter
Summary
Company Announcement Date: July 24, 2026
FDA Publish Date: July 27, 2026
Product Type: Drugs
. . .
